1. Home
  2. RANI vs LGCB Comparison

RANI vs LGCB Comparison

Compare RANI & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • LGCB
  • Stock Information
  • Founded
  • RANI 2012
  • LGCB 2011
  • Country
  • RANI United States
  • LGCB Japan
  • Employees
  • RANI N/A
  • LGCB N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • LGCB
  • Sector
  • RANI Health Care
  • LGCB
  • Exchange
  • RANI Nasdaq
  • LGCB Nasdaq
  • Market Cap
  • RANI 17.0M
  • LGCB 19.2M
  • IPO Year
  • RANI 2021
  • LGCB 2023
  • Fundamental
  • Price
  • RANI $0.53
  • LGCB $2.70
  • Analyst Decision
  • RANI Strong Buy
  • LGCB
  • Analyst Count
  • RANI 4
  • LGCB 0
  • Target Price
  • RANI $7.75
  • LGCB N/A
  • AVG Volume (30 Days)
  • RANI 4.6M
  • LGCB 8.3K
  • Earning Date
  • RANI 08-05-2025
  • LGCB 07-03-2025
  • Dividend Yield
  • RANI N/A
  • LGCB N/A
  • EPS Growth
  • RANI N/A
  • LGCB N/A
  • EPS
  • RANI N/A
  • LGCB N/A
  • Revenue
  • RANI $1,200,000.00
  • LGCB $8,993,265.00
  • Revenue This Year
  • RANI N/A
  • LGCB N/A
  • Revenue Next Year
  • RANI N/A
  • LGCB N/A
  • P/E Ratio
  • RANI N/A
  • LGCB N/A
  • Revenue Growth
  • RANI N/A
  • LGCB 5.80
  • 52 Week Low
  • RANI $0.39
  • LGCB $1.22
  • 52 Week High
  • RANI $3.75
  • LGCB $33.30
  • Technical
  • Relative Strength Index (RSI)
  • RANI 50.55
  • LGCB 62.46
  • Support Level
  • RANI $0.40
  • LGCB $2.47
  • Resistance Level
  • RANI $0.45
  • LGCB $2.59
  • Average True Range (ATR)
  • RANI 0.07
  • LGCB 0.09
  • MACD
  • RANI 0.00
  • LGCB 0.02
  • Stochastic Oscillator
  • RANI 30.27
  • LGCB 100.00

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

Share on Social Networks: